Leuprolide Acetate Suspension for injection, Norethindrone Acetate Oral tablet
What is this medicine?
LEUPROLIDE; NORETHINDRONE (loo PROE lide; nor eth IN drone) is a combination of 2 medicines that help to treat endometriosis in women. Leuprolide is an injection that acts like a natural hormone in the body. Norethindrone is a tablet that is a female hormone.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
breast, cervical, or vaginal cancer
high blood pressure
history of blood clots
history of stroke
unusual vaginal bleeding
an unusual or allergic reaction to leuprolide, norethindrone, other medicines, foods, dyes, or preservatives
pregnant or trying to get pregnant
How should I use this medicine?
Leuprolide is for injection into a muscle. It is given by a health care professional in a hospital or clinic setting.
Take the norethindrone tablets by mouth with a glass of water. You may take it with or without food. Follow the directions on the prescription label. Take this medicine at the same time each day. Do not take your medicine more often than directed.
A patient information sheet will be given with each prescription and refill. Read this sheet carefully each time. The sheet may change frequently.
Talk to your pediatrician regarding the use of this medicine in children. Special care may be needed.
Overdosage: If you think you've taken too much of this medicine contact a poison control center or emergency room at once.
NOTE: This medicine is only for you. Do not share this medicine with others.
What if I miss a dose?
For the leuprolide injection: Keep your appointments for follow-up doses as directed. It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.
Norethindrone tablets: If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.
What may interact with this medicine?
Do not take this medicine with any of the following medications:
amprenavir or fosamprenavir
This medicine may also interact with the following medications:
antibiotics or medicines for infections, especially rifampin, rifabutin, rifapentine, and griseofulvin, and possibly penicillins or tetracyclines
barbiturate medicines, such as phenobarbital
herbal or dietary supplements, like black cohosh or DHEA
ritonavir or other medicines for HIV infection or AIDS
St. John's wort
What should I watch for while using this medicine?
Tell your doctor or healthcare professional if your symptoms do not start to get better or if they get worse.
Talk to your doctor about using a method of birth control that does not contain hormones.
Using this medicine for a long time may increase your risk of low bone mass. Do not use for more than 2 six-month treatments. Talk to your doctor about bone health.
If you have any reason to think you are pregnant, stop taking this medicine right away and contact your doctor or health care professional.
What side effects may I notice from receiving this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
breast swelling, tenderness
changes in vision
loss of memory
pain in your legs or groin
shortness of breath, chest pain, swelling in a leg
swelling of the feet and legs
unusually weak or tired
Side effects that usually do not require medical attention (Report these to your doctor or health care professional if they continue or are bothersome.):
change in menstrual flow
loss of appetite
pain, redness, or irritation at site where injected
skin problems or acne
Where should I keep my medicine?
Keep out of the reach of children.
Store the norethindrone tablets at room temperature between 20 and 25 degrees C (68 and 77 degrees F). Throw away any unused medicine after the expiration date.
Leuprolide injection is given in a hospital or clinic and will not be stored at home.
March 21, 2017
U.S. FDA-approved Package Insert